Germline mutations in tumor suppressors BRCA1/2 result in an increased risk of developing breast, ovarian and others, such as pancreas, stomach and prostate cancers [4, 5]: the neoplastic process will rise if the wild-type gene is lost or inactivated. The gene discussed is BRCA1; the disease is prostate carcinoma.